Affiliation:
1. DEPARTMENT OF CLINICAL PHARMACOLOGY, WROCLAW MEDICAL UNIVERSITY, WROCLAW, POLAND
Abstract
Kidney stone disease (nephrolithiasis; urolithiasis) is a clinical entity with long-term course and recurrence, primarily affecting mature and ageing men, involving the formation and presence of urinary stones in the kidneys and urinary tract. The pathogenesis of this disorder is complex and still not fully understood. A rare, potentially modifiable, form of kidney stone disease takes the form of drug-induced urinary stones.
The aim of the review was a brief description of the classification and pathophysiology of kidney stone disease, along with the short characteristics of drug-induced urinary stones. This type of stones is formed as a result of crystallisation in the kidneys and urinary tract of sparingly soluble drugs and their metabolites, or as a result of metabolic changes caused by drugs, predestinating the development of stones containing endogenous compounds.
Conclusion: Therefore, during treatment with the use of drugs with high lithogenic potential, the safety of pharmacotherapy should be monitored in the context of its increased risk of developing urinary stones.
Reference28 articles.
1. 1. Tefekli A, Cazayirli F. The history of urinary stones: in parallel with civilization. Sci World J. 2013;Article ID 423964, 5 pages.
2. 2. Domingos Serra A. History of urinary lithiasis – the beginnings of nephrology. Rev Port Nephrol Hipert. 2004;18(3):143-153.
3. 3. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2020. http://uroweb.org/guidelines/compilations-of-all-guidelines/.
4. 4. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13(Suppl. 3):S45-S50.
5. 5. Jayaraman UC, Gurusamy A. Review on uro-lithiasis pathophysiology and aesculapian discussion. IOSR J Pharm. 2018;8(2):30-42.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献